# Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

> **NCT02975609** · PHASE2 · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 100 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **RADIATION:** Conventional Fractionated Radiotherapy
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT02975609
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975609, "Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02975609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*